Scarica l'app Stockscreener
28.34
3.06%
0.815
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Roivant Sciences Ltd. (ROIV): David Einhorn Trims Stake - Insider Monkey
Roivant Sciences: Moderna Settlement, Brepocitinib Support A Long-Term Buy (NASDAQ:ROIV) - Seeking Alpha
Roivant Sciences Ltd. (ROIV): One of the Best Stocks to Buy According to Joe Edelman - Yahoo Finance
Roivant Sciences Ltd. (ROIV) Stock Analysis: Exploring a Potential 30% Upside in Healthcare Biotech - DirectorsTalk Interviews
Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential - Insider Monkey
Roivant Sciences Ltd. $ROIV Stake Cut by Impax Asset Management Group plc - MarketBeat
Roivant Sciences (ROIV) Valuation Check After Recent Share Price Volatility - simplywall.st
M&T Bank Corp Takes Position in Roivant Sciences Ltd. $ROIV - MarketBeat
Montes Archimedes Acquisition (ROIV) upgraded to buy: Here's what you should know - MSN
Citigroup Maintains Roivant Sciences (ROIV) Buy Recommendation - MSN
Price-Driven Insight from (ROIV) for Rule-Based Strategy - Stock Traders Daily
Roivant Sciences Insider Sold Shares Worth $5,918,000, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences (NASDAQ:ROIV) CEO Eric Venker Sells 200,000 Shares - MarketBeat
Roivant Sciences(ROIV.US) Officer Sells US$5.92 Million in Common Stock - Moomoo
Roivant (NASDAQ: ROIV) president exercises 200K options, sells shares - Stock Titan
Roivant Sciences (ROIV) CFO awarded 60,644 RSUs and 84,026 stock options - Stock Titan
Roivant Sciences (ROIV) grants CAO new RSUs and stock options - Stock Titan
Roivant Sciences (ROIV) director gets share award, settles taxes in stock - Stock Titan
Roivant Sciences (ROIV) director gets fully vested 670-share award - Stock Titan
Roivant Sciences (ROIV) director gets share grant with tax netting - Stock Titan
J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Maintains Target Price $35 - Moomoo
Roivant Sciences Insider Sold Shares Worth $8,449,810, According to a Recent SEC Filing - marketscreener.com
Roivant Sciences (ROIV) CEO sells 289,774 shares around $29 - Stock Titan
Roivant (ROIV) Stock Insider Ownership (Smart Money Outflows) 2026-04-20Shared Trade Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Roivant Sciences Ltd. (ROIV) Wins Orphan Drug Status in Japan for Mosliciguat - MSN
J.P. Morgan Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $35 - Moomoo
ROIV Maintained by Piper Sandler -- Price Target Raised to $40 - GuruFocus
Form 144 | Roivant Sciences(ROIV.US) Officer Proposes to Sell 8.45 Million in Common Stocks - Moomoo
Matthew Gline sells $8.44M in ROIV stock (ROIV) — insider Form 144 filing - Stock Titan
Piper Sandler Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $40 - Moomoo
Piper Sandler Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $40 - Moomoo
Consolidated Portfolio Review Corp Acquires Shares of 276,530 Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences (ROIV): A Clinical Trial Win Meets a Phase 3 Failure - Insider Monkey
Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight - GlobeNewswire Inc.
Goldman Sachs Maintains Roivant Sciences(ROIV.US) With Buy Rating, Raises Target Price to $41 - Moomoo
Roivant Sciences Ltd. (NASDAQ:ROIV) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
10 Must-Buy US Stocks to Buy Right Now - Insider Monkey
A Look At Roivant Sciences (ROIV) Valuation As Analyst Upgrades And Brepocitinib Progress Lift Sentiment - simplywall.st
(ROIV) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Elevate Capital Advisors LLC Sells 36,236 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences: How Its Unique Deal Structure With Pfizer Could Shape Long-Term Value! - Smartkarma
Is Brepocitinib’s LPP Trial And Mixed Batoclimab Data Altering The Investment Case For Roivant Sciences (ROIV)? - simplywall.st
Insider Sell Alert: Jennifer Humes Sells Shares of Roivant Scien - GuruFocus
Montes Archimedes Acquisition (ROIV) Raised to Buy: Key Information You Need - Bitget
Insider Selling: Roivant Sciences (NASDAQ:ROIV) CAO Sells 13,538 Shares of Stock - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Roivant Sciences (ROIV), Boston Scientific (BSX) - The Globe and Mail
What happens to Roivant (ROIV) Stock after earnings | Price at $28.44, Up 0.96%Stock Analysis - Xã Thanh Hà
Roivant Sciences Ltd. (ROIV) Stock forecasts - Yahoo Finance UK
Capricorn Fund Managers Ltd Buys 247,000 Shares of Roivant Sciences Ltd. $ROIV - MarketBeat
Roivant Sciences Ltd. (ROIV) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
1.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):